logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research - Dallas, Texas

Verified
+16823481169
Source: Site record.
https://velocityclinicaltrials.com/locations/velocity-clinical-research-dallas

Basic Information

Site Overview

Source: Google.

Velocity's research site in Dallas was founded in 1990 as Dallas Diabetes Research Center and acquired by Velocity in 2022. With hundreds of endocrinology studies completed, the Dallas site is a leader in conducting diabetes, obesity, and NASH trials. The Dallas team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Research institute

Business Subcategory

Source: Google. Research institute
Source: Trial-derived.
63Total Trials
Source: Trial-derived.
7Recruiting Trials
Source: Trial-derived.
20Active Trials
Source: Trial-derived.
42Completed Trials
Source: Trial-derived.
27Unique Conditions
Source: Trial-derived.
15Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Diabetes Mellitus, Type 2 (20)Source: Trial-derived. Obesity (18)Source: Trial-derived. Type 2 Diabetes (7)Source: Trial-derived. Type 2 Diabetes Mellitus (6)Source: Trial-derived. Overweight (4)Source: Trial-derived. Hypercholesterolemia (3)Source: Trial-derived. Obesity or Overweight (3)Source: Trial-derived. Diabetes Mellitus, Type 1 (2)

Sponsors

Source: Trial-derived. Novo Nordisk A/S (42)Source: Trial-derived. Hoffmann-La Roche (3)Source: Trial-derived. Merck Sharp & Dohme LLC (3)Source: Trial-derived. Biomea Fusion Inc. (2)Source: Trial-derived. Boehringer Ingelheim (2)Source: Trial-derived. Regeneron Pharmaceuticals (2)Source: Trial-derived. Regor Pharmaceuticals Inc. (2)Source: Trial-derived. Corbus Pharmaceuticals Inc. (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Continuous glucose monitoring
Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)
Source: AI-inferred. DEXA Scan
Source: AI-inferred. ETDRS 4 m visual-acuity lane
Source: AI-inferred. Fundus photography
Source: AI-inferred. MRI proton density fat fraction
Source: AI-inferred. Treadmill / stress testing

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Specimen packaging and shipment

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Liver biopsy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Blood glucose meter monitoring
Source: AI-inferred. Ankle-brachial and toe-brachial index measurement
Source: AI-inferred. App-based insulin dose guidance
Source: AI-inferred. Capillary blood glucose monitoring
Source: AI-inferred. Electronic participant diary platform
Source: AI-inferred. Fundus examination
Source: AI-inferred. Home study visit (provider not specified)
Source: AI-inferred. Ophthalmologic examination